using Pradaxa (dabigatran) for more than atrial fibrillation

We're getting questions about using Pradaxa (dabigatran) for more than atrial fibrillation.

There's some evidence for other indications...but these aren't FDA approved and there are other limitations.

Treating venous thromboembolism. Pradaxa 150 mg BID for 6 months seems to work as well as warfarin to treat acute deep venous thrombosis or pulmonary embolism...and has a similar bleeding risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote